ClinicalTrials.gg
RecruitingNCT07456202Updated Jul 13, 2026

Menstrual Status, Anesthetic Consumption, and PONV

An observational study in Menstrual Cycle, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Ankara Etlik City Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.

Planned enrollment
6th of 25
120 · median 100
Started
2026
with 11 others
Observational
25 of 96
9 open now
Primary completion
2026-08
later than 13 of 22 live
Registered
85th of 96
by date
Lead sponsor
4 of 96
Ankara Etlik City Hospital

Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 6th largest by planned enrollment of the 25 observational ones that give a count, is one of 12 that started in 2026, is one of 25 observational ones, reaches primary completion later than 13 of the 22 other live ones, and was the 85th registered.

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

Browse Postoperative Nausea and Vomiting studies →

Open to participants now

22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Postoperative Nausea and Vomiting studies recruiting now, 22 (33%) set no upper age limit and 38 (58%) stop at 75 or younger; 15 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, or all of them as a file.
02

Study summary

This prospective observational cohort study aims to evaluate the association between menstrual phase (determined by postoperative serum progesterone levels), intraoperative anesthetic consumption, and the incidence and severity of postoperative nausea and vomiting (PONV) in female patients undergoing cholecystectomy. Intraoperative anesthetic requirements will be recorded, and postoperative nausea and vomiting will be assessed using standardized scoring systems.

Read the detailed description

Hormonal fluctuations during the menstrual cycle may influence anesthetic requirements and susceptibility to postoperative nausea and vomiting (PONV). However, the relationship between menstrual phase and intraoperative anesthetic consumption remains unclear.

This prospective observational cohort study will include female patients undergoing elective cholecystectomy under general anesthesia. No intervention will be applied beyond standard clinical practice. Intraoperative anesthetic drug consumption will be recorded quantitatively. Postoperative nausea and vomiting will be evaluated during the early postoperative period using validated assessment tools.

03

Conditions studied

  • Menstrual Cycle

Keywords

  • Anesthetic Consumption
  • Luteal Phase
  • Follicular Phase
  • Postoperative Nausea and Vomiting
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of female patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II-III who are scheduled for elective laparoscopic cholecystectomy under general anesthesia. Participants will be classified according to hormonal status (follicular phase, luteal phase, or postmenopausal) based on postoperative serum progesterone levels. All patients will receive standard perioperative care, and no experimental intervention will be applied.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 18 to 65 years
  • (ASA) physical status I-II-III
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia
  • Willing and able to provide written

Exclusion criteria

Exclusion Criteria:

  • Age outside the specified range (younger than 18 or older than 65 years)
  • Male patients
  • (ASA) physical status ≥ IV
  • Severe systemic comorbidities (e.g., significant cardiovascular, hepatic, renal, or pulmonary disease)
  • Conversion from laparoscopic to open cholecystectomy
  • History of alcohol, drug, or substance abuse
  • Visual or hearing impairment interfering with study assessments
  • Current hormone replacement therapy
  • Use of oral
  • Preoperative nausea or vomiting
  • History of severe postoperative nausea and vomiting
  • Neurological or psychiatric disorders affecting assessment reliability
  • Hemodynamic instability during surgery
  • Postoperative admission to intensive care unit
  • Acute cholecystitis at the time of surgery
  • Refusal to participate or inability to provide
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Follicular Phase Group

    Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the follicular phase of the menstrual cycle based on postoperative serum progesterone levels. No experimental intervention will be applied. Intraoperative anesthetic consumption and postoperative nausea and vomiting will be recorded as part of routine perioperative management.

  • Luteal Phase Group

    Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the luteal phase of the menstrual cycle according to postoperative serum progesterone levels. No intervention beyond standard clinical care will be performed. Anesthetic drug consumption and postoperative nausea and vomiting outcomes will be documented.

  • Postmenopausal Group

    Female patients undergoing cholecystectomy under general anesthesia who are postmenopausal. These patients will receive standard perioperative care. Intraoperative anesthetic requirements and postoperative nausea and vomiting will be assessed and compared with other hormonal status groups.

06

What researchers measure

Primary outcomes

  1. Intraoperative Anesthetic Agent Consumption

    Total amount of anesthetic agents administered during surgery, recorded quantitatively (e.g., mg of intravenous agents and/or minimum alveolar concentration-hours of volatile anesthetics).

    Time frame: From induction of anesthesia to the end of surgery

Secondary outcomes

  1. Perioperative Hemodynamic Changes

    Changes in mean arterial pressure recorded intraoperatively at predefined time intervals.

    Time frame: From induction of anesthesia until the end of surgery

  2. Postoperative Vomiting

    Incidence of vomiting episodes recorded during the postoperative period.

    Time frame: Within 24 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will be available upon reasonable request to the corresponding investigator, following publication of the study results, and subject to institutional and ethical approval.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 6 months after publication and available for up to 3 years.

Access criteria: Data will be shared electronically after approval of a formal data request and signing of a data use agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.

Of 52 non-industry observational studies under Postoperative Nausea and Vomiting, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 37. This study's planned 5 months is below that.

Counting every sponsor, half of 52 studies reached it within 11 months; a quarter within 4 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2026
First posted
Mar 6, 2026
StartActual
Mar 7, 2026
Primary completionEst.
Aug 15, 2026
CompletionEst.
Aug 16, 2026
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07456202
Responsible party
oya Çimen (MD, Specialist in Anesthesiology, Ankara Etlik City Hospital) — Principal investigator
First posted
Mar 6, 2026
Start date
Mar 7, 2026
Primary completion
Aug 15, 2026 (estimated)
Completion
Aug 16, 2026 (estimated)
Last update
Jul 13, 2026

Study contacts

oya Çimen, Specialist in Anesthesiology
Contact
oya.cimen@hotmail.com
+905334494750
Fethi Gültop, Specialist in Anesthesiology
Contact
fethigultop@yahoo.com
+905052260067
oya çimen, Specialist in Anesthesiology
principal investigator · Ankara Etlik City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion